-
-
-
-
-
-
-
Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports First Quarter 2023 Financial ResultsĀ and Provides Business Update
-
-
-
-
-
-
-
Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of Directors
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) to Acquire Purnovate, a Developer of Potential Therapies for Non-Opioid Pain Reduction and Treatment of Addiction
-
-
-
-
1,185,404 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

